Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

The young breast cancer patient: A tertiary institution’s experience

Domaine:

healthcare

Type de record:

paper
Créateur:
YvoMauOluTha
Éditeur:
AOS
Hôte:
Background: Breast cancer (BC) in sub-Saharan Africa affects not only older females but also those aged ≤ 40 years. At Chris Hani Baragwanath Academic Hospital (CHBAH), females with suspicious breast lesions undergo combined mammography and ultrasound with integrated Breast Imaging Reporting and Data System (BI-RADS) assessment to guide biopsy. The diagnostic performance of this approach in younger females remains clinically relevant because of increased breast density. Aim: To assess the concordance between bimodal BI-RADS classification and histopathological diagnosis in females aged ≤ 40 years with biopsy-confirmed BC. Setting: Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa, using data from the South African Breast Cancer and HIV Outcomes (SABCHO) cohort. Methods: A retrospective review of females aged ≤ 40 years diagnosed with invasive BC over seven years was performed. Clinical and demographic characteristics were described, and concordance between bimodal BI-RADS classification and histopathological diagnosis was assessed. Results: Of 354 patients identified, 309 met the inclusion criteria. The mean age was 35.2 ± 3.9 years, and invasive ductal carcinoma was the predominant subtype (93.5%). Concordance between bimodal BI-RADS classification and histopathological diagnosis was 97.7%. BI-RADS 5 was the most common imaging category, while discordant cases were confined to stage I, stage II and stage III disease. Most patients presented with locally advanced disease. Conclusion: Bimodal BI-RADS assessment showed high concordance with histopathological diagnosis in females aged ≤ 40 years with biopsy-confirmed BC, supporting the use of combined mammography and ultrasound for evaluating suspicious breast lesions in this setting. Contribution: This study adds evidence on the concordance of bimodal BI-RADS assessment with histopathological diagnosis in young females with BC in sub-Saharan Africa.

Visit

doi.org

Licenses

https://creativecommons.org/licenses/by/4.0

Similaires

BREAST CANCER IN YOUNG ADULTS: A CASE SERIESCancer Incidence in Nigeria: A Tertiary Hospital ExperienceAdvanced Breast Cancer in Nigeria: A Single Centre ExperienceAbstract B18: Exploring the lived experience of young African American breast cancer survivorship: Early results toward informing a psychoeducational interventionUnderstanding the Breast Cancer Experience of Women in East Africa: A Qualitative StudyPatient demographics and germline mutation patterns across breast cancer molecular subtypes in a tertiary academic medical center: A retrospective study (October 2023–October 2025).

BREAST CANCER IN YOUNG ADULTS: A CASE SERIES

Introduction: Breast cancer is the most common cancer among wo

Cancer Incidence in Nigeria: A Tertiary Hospital Experience

Background: Cancer is a poorly addressed major cause of morbidity and mortality in Nigeria.Aim: The

Advanced Breast Cancer in Nigeria: A Single Centre Experience

Background: Breast cancer is the most common cancer globally and in Nigeria, it constitutes about 12

Abstract B18: Exploring the lived experience of young African American breast cancer survivorship: Early results toward informing a psychoeducational intervention

Abstract Background/Purpose Recent data indicate that 11% of the 2

Understanding the Breast Cancer Experience of Women in East Africa: A Qualitative Study

Background: Breast cancer is one of the leading causes of premature death in women in East Africa. T

Patient demographics and germline mutation patterns across breast cancer molecular subtypes in a tertiary academic medical center: A retrospective study (October 2023–October 2025).

e13142 Background: